FDA Panel Overwhelmingly Backs Approval Of Anti-Obesity Pill A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a drug which the FDA previously rejected due to safety concerns.

More From CBS Philly

CBSPhillyStyle
Top Spots To Say Goodbye To Summer

Listen Live